ClearPoint Neuro, Inc. (CLPT) NASDAQ
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Currency In USD
Address
120 S. Sierra Avenue
Solana Beach, CA 92075
United States of America (the)
Phone
888 287 9109
Sector
Healthcare
Industry
Medical - Devices
Employees
115
First IPO Date
May 22, 2012
| Name | Title | Pay | Year Born |
| Joseph Michael Burnett | President, Chief Executive Officer & Director | 1.01M | 1977 |
| Robert C. Korn | Senior Vice President of Sales & Business Development | 305,123 | 1965 |
| Jeremy Stigall | Chief Business Officer | 522,809 | 1984 |
| Danilo D'Alessandro | Chief Financial Officer | 554,360 | 1985 |
| Mazin Sabra | Chief Operating Officer | 0 | 1980 |
| Ellisa Cholapranee | General Counsel & Secretary | 0 | N/A |
| Mary McNamara-Cullinane | Senior Vice President of Regulatory Affairs | 0 | N/A |
| Megan Faulkenberry | Senior Vice President of Quality | 0 | N/A |
| Paul S. Larson FAANS | Chief Medical Officer | 0 | N/A |
ClearPoint Neuro, Inc. is a medical technology firm primarily operating within the United States. The company specializes in developing and commercializing sophisticated systems that facilitate minimally invasive brain surgeries, guided by real-time magnetic resonance imaging (MRI) during the procedure. Among its core offerings is the ClearPoint system, designed for the precise placement of deep brain stimulation electrodes, biopsy needles, and for the controlled infusion of medications and laser catheters directly into the brain. It also provides the ClearPoint Neuro Navigation System, which is specifically engineered for MRI suite environments. ClearPoint Neuro maintains strategic partnerships and licensing agreements with prominent institutions and companies, including Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and the University of California, San Francisco. Initially established in 1998 and headquartered in Solana Beach, California, the company operated as MRI Interventions, Inc. before rebranding to ClearPoint Neuro, Inc. in February 2020.